Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yutong Liu, Ling Zhang, Zitai Ma, Li Tian, Yingchi Liu, Yuqing Liu, Qi Chen, Yanchun Li & Enlong Ma. (2019) Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion. Free Radical Research 53:7, pages 758-767.
Read now
Read now
Olexiy Aseyev, Joana M. Ribeiro & Fatima Cardoso. (2016) Review on the clinical use of eribulin mesylate for the treatment of breast cancer. Expert Opinion on Pharmacotherapy 17:4, pages 589-600.
Read now
Read now
Yongsheng Jia, Liyan Zhou, Chen Tian, Yehui Shi, Chen Wang & Zhongsheng Tong. (2015) Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death. OncoTargets and Therapy 8, pages 3371-3381.
Read now
Read now
Articles from other publishers (18)
Fengting YanKristine J. Rinn, Jonathon A. KullnatAimee Y. WuMaura D. EnnettElizabeth L. ScottHenry G. Kaplan. (2022) Response of Leptomeningeal Metastasis of Breast Cancer With a HER2/neu Activating Variant to Tucatinib: A Case Report. Journal of the National Comprehensive Cancer Network 20:7, pages 745-752.
Crossref
Crossref
María Paz Saldías, Diego Maureira, Octavio Orellana-Serradell, Ian Silva, Boris Lavanderos, Pablo Cruz, Camila Torres, Mónica Cáceres & Oscar Cerda. (2021) TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Min Ho Park, Soo Jung Lee, Woo Chul Noh, Chang Wan Jeon, Seok Won Lee, Gil Soo Son, Byung-In Moon, Jin Sun Lee, Sung Soo Kang, Young Jin Suh, Geumhee Gwak, Tae Hyun Kim, Young Bum Yoo, Hyun-Ah Kim, Min Young Kim, Ju Yeon Kim & Joon Jeong. (2020) A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK). The Breast 54, pages 121-126.
Crossref
Crossref
Juan Garona, Marina Pifano, Giselle Ripoll & Daniel F. Alonso. 2020. Vasopressin. Vasopressin
259
289
.
Huang‐Tz Ou, Wei‐Pang Chung, Pei‐Fang Su, Tzu‐Hsuan Lin, Ji‐Ying Lin, Yao‐Chun Wen & Wei‐Tse Fang. (2019) Health‐related quality of life associated with different cancer treatments in Chinese breast cancer survivors in Taiwan. European Journal of Cancer Care 28:4.
Crossref
Crossref
Kenichi Inoue, Jun Ninomiya, Tsuyoshi Saito, Katsuhiko Okubo, Takashi Nakakuma, Hirofumi Yamada, Kei Kimizuka & Tohru Higuchi. (2019) Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial. Investigational New Drugs 37:3, pages 538-547.
Crossref
Crossref
Xue Yang, Cui-hong Zhu, Rui Cao, Jian Hao & Xiong-zhi Wu. (2018) Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer. Chinese Journal of Integrative Medicine 24:10, pages 741-745.
Crossref
Crossref
Chelsea Snyder, Lanlan Yu, Tin Ngo, Daniel Sheinson, Yuda Zhu, Min Tseng, Dinah Misner & Karin Staflin. (2018) In vitro assessment of chemotherapy-induced neuronal toxicity. Toxicology in Vitro 50, pages 109-123.
Crossref
Crossref
Ruth Espinosa Aunión, Carmen Aida Ramírez Ruda, Carmela Rodríguez López, Teresa Curiel García, José Ángel García Saénz & Rafael López López. (2018) Experience with eribulin in patients with breast cancer and cutaneous metastases: case studies. Future Oncology 14:7s, pages 37-44.
Crossref
Crossref
Erica Quaquarini, Federico Sottotetti, Daniela D’Ambrosio, Alberto Malovini, Stefania Morganti, Arianna Marinello, Lorenzo Pavesi & Mara Frascaroli. (2017) Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cancer patients. Future Oncology 13:11s, pages 11-23.
Crossref
Crossref
Katherine Zlotkowski, William M. Hewitt, Pengcheng Yan, Heidi R. Bokesch, Megan L. Peach, Marc C. Nicklaus, Barry R. O’Keefe, James B. McMahon, Kirk R. Gustafson & John S. SchneeklothJr.Jr.. (2017)
Macrophilone A: Structure Elucidation, Total Synthesis, and Functional Evaluation of a Biologically Active Iminoquinone from the Marine Hydroid
Macrorhynchia philippina
. Organic Letters 19:7, pages 1726-1729.
Crossref
Crossref
Pin Zhang, Tao Sun, Qingyuan Zhang, Zhongyu Yuan, Zefei Jiang, Xiao Jia Wang, Shude Cui, Yuee Teng, Xi-Chun Hu, Junlan Yang, Hongming Pan, Zhongsheng Tong, Huiping Li, Qiang Yao, Yongsheng Wang, Yongmei Yin, Ping Sun, Hong Zheng, Jing Cheng, Jinsong Lu, Baochun Zhang, Cuizhi Geng, Jian Liu, Roujun Peng, Min Yan, Shaohua Zhang, Jian Huang, Li Tang, Rongguo Qiu & Binghe Xu. (2017) Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial. The Lancet Oncology 18:3, pages 371-383.
Crossref
Crossref
Juan Garona, Marina Pifano, Maria B. Pastrian, Daniel E. Gomez, Giselle V. Ripoll & Daniel F. Alonso. (2016) Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models. Clinical & Experimental Metastasis 33:6, pages 589-600.
Crossref
Crossref
Wei Wang, Bhavitavya Nijampatnam, Sadanandan E. Velu & Ruiwen Zhang. (2016) Discovery and development of synthetic tricyclic pyrroloquinone (TPQ) alkaloid analogs for human cancer therapy. Frontiers of Chemical Science and Engineering 10:1, pages 1-15.
Crossref
Crossref
Haiyan Li, Qiaoping Wang, Lihua Dong, Chuanlan Liu, Zhen Sun, Ling Gao & Xiujie Wang. (2015) Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Leslie Wilson, Manu Lopus, Herbert P. Miller, Olga Azarenko, Stephen Riffle, Jennifer A. Smith & Mary Ann Jordan. (2015) Effects of Eribulin on Microtubule Binding and Dynamic Instability Are Strengthened in the Absence of the βIII Tubulin Isotype. Biochemistry 54:42, pages 6482-6489.
Crossref
Crossref
Guido Cavaletti & Paola Marmiroli. (2015) Chemotherapy-induced peripheral neurotoxicity. Current Opinion in Neurology 28:5, pages 500-507.
Crossref
Crossref
Yanhong Lv, Guijuan Zhang, Yi Ma, Min Ma, Rui Liao, Jingfang Xiang, Ruixue Chen, Xianxin Yan, Fengjie Bie, Maojie Huang & Shijie Liang. (2015) Shenqi Fuzheng Injection Combined with Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-13.
Crossref
Crossref